Showing results (191-200 of 277) with videos related to

Sort By:
Pageof 28
Journal of Neurochemistry|December 24, 2011
Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatumMariana Angoa-Pérez, Michael J Kane, Dina M Francescutti, et al.
Clinical and Translational Medicine|April 17, 2024
Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databasesImogen R Walpole, Farzana Y Zaman, Peinan Zhao, et al.
Healthcare (Basel, Switzerland)|October 27, 2022
Effective and Efficient Delivery of Genome-Based Testing-What Conditions Are Necessary for Health System Readiness?Don Husereau, Lotte Steuten, Vivek Muthu, et al.
Journal of Neurochemistry|December 5, 2012
Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMAMariana Angoa-Pérez, Michael J Kane, Denise I Briggs, et al.
Gastroenterology|April 21, 2009
Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancerAndrew V Biankin, James G Kench, Emily K Colvin, et al.
NPJ Genomic Medicine|February 17, 2025
Returning raw genomic data to research participants in a pediatric cancer precision medicine trialKristine Barlow-Stewart, Eliza Courtney, Mark Cowley, et al.
Genome Research|April 6, 2018
Optical mapping reveals a higher level of genomic architecture of chained fusions in cancerEva K F Chan, Daniel L Cameron, Desiree C Petersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: findings from the Adjuvant Colon Cancer Endpoints data setJoleen Hubbard, David M Thomas, Greg Yothers, et al.
NPJ Precision Oncology|June 24, 2021
Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncologyFrank P Lin, Subotheni Thavaneswaran, John P Grady, et al.
JAMA Oncology|March 20, 2020
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With OsteosarcomaLisa Mirabello, Bin Zhu, Roelof Koster, et al.
Pageof 28